← Back to Search

Avoidance Education for Diabetes Risk Reduction (NPETA-GD Trial)

N/A
Recruiting
Led By Erin Sweet, ND, MPH
Research Sponsored by Bastyr University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years old or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

NPETA-GD Trial Summary

This trial is testing whether certain chemicals in the environment can contribute to diabetes, and whether making changes to diet and lifestyle can help reduce this risk.

Who is the study for?
This trial is for adults with blood sugar control issues (HbA1c >= 5.7%) who don't already eat mostly organic food or drink filtered water. They must be able to consent remotely and not be on insulin treatments, planning surgeries, or unwilling to change their diet and lifestyle.Check my eligibility
What is being tested?
The study tests if a special program teaching people how to avoid certain environmental chemicals can lower these in the body and improve blood sugar levels. Participants will learn dietary and lifestyle changes over the course of the study.See study design
What are the potential side effects?
Since this intervention involves education on avoiding environmental toxins through diet and lifestyle changes rather than medication, there are no direct side effects like those associated with drugs.

NPETA-GD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

NPETA-GD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in percentile score of urinary excretion of toxicant marker metabolites pre and post three-week dietary and lifestyle intervention
Secondary outcome measures
Change in immediate glucose response measured by daily fasting and post-prandial blood glucose measurements.

NPETA-GD Trial Design

1Treatment groups
Experimental Treatment
Group I: Toxicant avoidance and glucose dysregulationExperimental Treatment1 Intervention
To investigate whether or not the excretion of urinary toxicant metabolites is reduced by dietary modification and lifestyle intervention in people with glucose dysregulation; whether the participant's ranked glucose dysregulation correlates with the amount and/or type of toxic metabolites excreted at baseline; and whether the body's immediate response to glucose is improved by the reduction of toxicant burden.

Find a Location

Who is running the clinical trial?

Bastyr UniversityLead Sponsor
25 Previous Clinical Trials
5,065 Total Patients Enrolled
1 Trials studying Diabetes
66 Patients Enrolled for Diabetes
Erin Sweet, ND, MPHPrincipal InvestigatorBastyr University

Media Library

Diabetes Clinical Trial 2023: Avoidance Education Highlights & Side Effects. Trial Name: NCT04821752 — N/A
Avoidance Education 2023 Treatment Timeline for Medical Study. Trial Name: NCT04821752 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor include those under the age of 35?

"This clinical trial seeks participants aged between 18 and 100. Furthermore, there are 11 investigations for minors under the age of eighteen, as well as 108 studies targeting adults over 65 years old."

Answered by AI

Does this research endeavor currently need new participants?

"According to the most up-to-date information on clinicaltrials.gov, this investigation was first published on May 1st 2022 and has been recently renewed as of July 26th. Recruitment is in progress for participants at present time."

Answered by AI

Who has the necessary qualifications to be admitted into this medical trial?

"This clinical trial is seeking 25 participants who have glucose intolerance and are between 18-100 years old."

Answered by AI

What is the current capacity of this clinical trial?

"Affirmative. According to clinicaltrials.gov, this research is actively enrolling participants since it was published on May 1st 2022 and was most recently updated on July 26th 2022. This experiment requires 25 individuals from a single location for its completion."

Answered by AI
~9 spots leftby Apr 2025